Pressemitteilung

Sustainable medicines supply: kick-off for a joint European initiative

17.11.2026 AOK Baden-Württemberg 4 Min. Lesedauer

European forum in Brussels: representatives from politics, public authorities, science and healthcare discuss common European standards for a sustainable medicines supply on the occasion of European Antibiotic Awareness Day

Group photo from the European Network Meeting in Brussels 2026
Group photo from the European Network Meeting in Brussels 2026
Deutsch English Français

Brussels. At the European forum “Sustainable Medicines Supply”, held at the Representation of the State of Baden-Württemberg in Brussels, representatives from politics, public authorities, science and healthcare met on Monday (16 November 2026) at the invitation of AOK Die AOK hat mit mehr als 20,9 Millionen Mitgliedern (Stand November 2021) als zweistärkste Kassenart… Baden-Württemberg to discuss a sustainable and resilient medicines supply in Europe. The event was deliberately held during the week of European Antibiotic Awareness Day. It highlighted existing approaches and discussed how they can be transferred to other European countries.

Alarming findings as a starting point

The discussion was based on findings from the national AOK community on the burden that antibiotic production places on the environment and on health. Since 2021, the AOK community has applied a sustainability criterion in its rebate contract tenders for antibiotics. Under this criterion, manufacturers commit to complying with effect-based maximum concentrations for production wastewater and to allowing independent on-site inspections. With this incentive for more environmentally sound production conditions, the AOK aims to counter the health problem of the spread of antimicrobial resistance caused by polluted production wastewater, and to minimize distortions of competition in the active pharmaceutical ingredient market in favor of clean production.

Under the leadership of AOK Baden-Württemberg, an independent institute has carried out more than 50 inspections at 22 production sites in China, India and Europe since 2021. At eleven sites, in some cases massive exceedances of environmental limit values were measured, both inside and outside the production facilities. For levofloxacin, the value measured in the production wastewater was more than 2,500 times above the threshold. These findings raise the question of how environmental standards along global supply chains can be effectively monitored and enforced, also with a view to the societal health problem of growing antibiotic resistance.

A global health problem requires a strong European response

The AOK community is taking an innovative approach to sustainable medicines supply, but as a local player it reaches its limits on a global issue of this kind. “We need solutions at the European level. With its measures to strengthen European supply chains and European production, the Critical Medicines Act (CMA) is fundamentally heading in the right direction. But what we also need is greater leverage in Europe, more transparency along the supply chain, and effective controls that require as little additional bureaucracy as possible,” said Johannes Bauernfeind, Chairman of the Executive Board of AOK Baden-Württemberg. For the first time in this format, the forum, held at the invitation of AOK Baden-Württemberg, brought together the key players on sustainable medicines supply.

Input from federal and state politics

The European-level policy discussion was framed by contributions from the federal and state governments. In a video message, the Parliamentary State Secretary to the Federal Minister of Health, Dr Georg Kippels, said: “Sustainability in healthcare is no longer a secondary aspect, but a central topic for the future.” He extended special thanks to AOK Baden-Württemberg for its commitment and its willingness to share its experience. Given the European and global dimensions of medicines production, this exchange at the European level is particularly worthwhile.

The Head of Administration of the Baden-Württemberg Ministry of Social Affairs, Labour and Health, Berthold Frieß, also welcomed the participants to the State Representation by video message and stressed: “A future-proof medicines production must combine three objectives: security of supply, sustainability and economic viability.” It is crucial, he said, that action at all levels – regional, national and European – is closely interlinked. “Today, an important contribution is being made by setting bezeichnet im Bereich der Gesundheitsförderung Lebensbereiche, in denen Menschen einen großen Teil… concrete impetus for a resilient and responsibly designed medicines production,” Frieß added.

Johannes Bauernfeind summed up: “The European forum in Brussels was the kick-off at European level to further advance sustainable medicines supply. We intend to consistently continue this path of joint exchange with politics, public authorities, science and manufacturers. In our view, the long-term goal must be a European sustainability certificate for medicines that brings together environmental standards and security of supply. We should avoid European patchwork, with different requirements and ideas of sustainability depending on the country. Only together will we be effective.”

2 passende Downloads

  • Sustainable drug supply for a healthy society

    Format: PDF | 268 KB

  • group photograph Brussels 2026

    Format: JPG | 1 MB | 2000 × 1333 px

    Lizenz: Dieses Angebot (Foto, MP3, PDF...) darf für private und kommerzielle nicht-werbliche Zwecke und in sozialen Medien genutzt werden. Bitte geben Sie die Quellenangabe an.

media contact

Portrait Dr. Jörg Schweigard
Pressesprecher

Dr. Jörg Schweigard

AOK Baden-Württemberg